Transcript Highlights:

• Thank you for sharing those experiences, and you had mentioned a pharmaceutical company.
• There are dedicated pharmaceutical companies that have invested tens, hundreds of millions of dollars
• Yes, I have a pretty good, healthy, I think, relationship with a lot of the pharmaceutical companies.
• I've had the opportunity to be involved in many research projects, different pharmaceutical companies
• I've had the opportunity to be involved in many research projects, different pharmaceutical companies

Keywords: 995, all

Summary: The hearing opened with the Senate and House chairs of the Joint Committee on Financial Services explaining that the day’s agenda would focus on health insurance and other insurance matters, with a large number of witnesses and a request for brief testimony. Legislators were taken out of order to accommodate their schedules, and the committee heard testimony on several bills, including coverage for hair prostheses for alopecia (H. 1223/S. 832), medically necessary oral and dental care for head and neck cancer survivors (H. 1258), modernizing fertility and family-building coverage (H. 715/H. 1190 and related bills), coverage for prosthetic devices to support physical activity for people with limb loss (the “So Everybody Can Move” bill), remediation coverage for home heating oil releases (S. 813/H. 1302), and expanded access to physical therapy for Ehlers-Danlos syndrome (H. 1170). A separate bill on sickle cell care and registry development (S. 788) was also discussed by Senator Liz Miranda. Witnesses largely offered personal stories and expert testimony in support of the bills. Advocates for alopecia coverage described the medical and emotional impact of hair loss, the high cost of quality wigs, and the argument that scalp and facial hair prostheses should be treated like other medically necessary prosthetics. Cancer survivors and supporters of H. 1258 said oral and dental care after head and neck cancer treatment is a quality-of-life issue and often not covered despite major out-of-pocket costs. Fertility specialists, LGBTQ+ advocates, and legislators supporting the modern family-building bills said the current infertility definition is outdated and discriminatory, excluding same-sex couples, people needing donors or gestational carriers, and others with medical barriers to conception. For the limb-loss bill, parents and adults with prosthetic needs stressed that activity-specific prostheses are essential for children and adults to run, swim, play sports, and stay healthy, but are often excluded from coverage. The home heating oil testimony focused on the financial devastation caused by residential oil spills and the need to make spill coverage automatic in homeowners policies. Environmental professionals and homeowners described cleanup costs ranging from tens of thousands to hundreds of thousands of dollars, the strict liability homeowners face, and the fact that many policyholders do not know the rider exists. The insurance industry testified in opposition to the mandatory-coverage approach, arguing for clearer distinctions between first- and third-party coverage, risk-mitigation standards, a delayed effective date, and more emphasis on education and notification rather than mandates. Committee members pressed the industry witness on why agents do not routinely tell customers about the rider and suggested that the issue may require broader disclosure by insurers, agents, and fuel dealers. No votes were taken during the hearing; the committee heard testimony and discussed possible compromise language and future action.

Transcript Highlights:

• Who received pharmaceuticals? How much the pharmaceuticals cost?
• I've asked for information on a certain type of pharmaceutical, three different classes, and all I could
• generate from ACA was a number of people on those pharmaceuticals.
• Pharmaceuticals—when I asked Representative Gonzalez Pittman, I certainly appreciate the nature of the

Summary: The subcommittee heard updates on several major technology modernization efforts, beginning with the Department of Financial Services’ Florida PALM project, which is replacing the state’s decades-old FLAIR accounting system. DFS described PALM as a statewide effort affecting all three branches of government, with cash management already live and the remaining financial management, payroll, and data warehouse components still in development. Officials said the project began in 2014, was restructured after a 2022 legislative pause, and is now being recommended for a go-live delay from January 2026 to July 2026. Members asked about governance, staffing, contract structure, cost growth, and maintenance costs; DFS said the contract is deliverable-based, the current amendment would add a net $2.2 million, and post-go-live maintenance is expected to be about $13 million annually under the current contract through July 2027. The Agency for Health Care Administration then updated the committee on the FX Medicaid enterprise modernization program. AHCA explained that federal CMS directed states to move from monolithic Medicaid systems to a modular approach, leading Florida to procure separate vendors for integration services, data warehouse, unified operations, provider services, and claims processing, with pharmacy benefits still to be procured. Officials said the project has spent about $334 million to date, with most costs federally matched, and requested $189.95 million for the upcoming year. They also highlighted a 2024 special assessment that produced 81 recommendations, most tied to staffing shortages, and said the Legislature added 47 FTEs, with 17 currently filled or being filled. Members asked about governance changes, production status, data access, and future technology maintenance; AHCA said some components are operational, the data warehouse is nearing certification, and the agency is working to keep the system adaptable and nonproprietary. The Department of Children and Families presented its Access modernization project, which is replacing a mainframe-based eligibility system used for SNAP, TANF, Medicaid assistance, and related programs. DCF said the six-year, $205 million project is in its third year and has already delivered a new customer portal with mobile access, multi-factor authentication, and fraud protections, while also building a worker portal, document management, community partner tools, and workload management functions. The agency said it is requesting $36.625 million for the next fiscal year, the same as last year, and emphasized that the project has remained on schedule and on budget by breaking work into smaller modules and using strong vendor and staff support. Members praised the project’s progress and asked about cybersecurity testing and the long delay before modernization began; DCF said security requirements were built in from the outset and that the remaining work will focus on moving staff off the legacy mainframe and modernizing notices and back-end processes.

Transcript Highlights:

• PBMs were originally created to negotiate drug prices with pharmaceutical manufacturers.
• Do you believe that pharmaceutical manufacturers are going to maintain the status quo?
• How do you feel about how pharmaceutical manufacturers would treat that in the event that negotiation

Summary: The Senate Insurance Committee met on May 13, 2026, adopted the May 6 minutes, and then took up several bills dealing with pharmacy benefit managers, prescription access, behavioral health coverage, and Citizens Property Insurance. HB 938, as amended, was the main PBM reform measure. After the committee adopted a large amendment set that narrowed the bill, members heard extensive testimony in support from Mark Bloom, Justin Joseph of Capital Rx, and Kathy Ue of Pontchartrain Cancer Center, all emphasizing transparency, pass-through pricing, reverse auctions, and patient access. Supporters described savings from reverse auctions and administrative models, while the cancer center testified that PBM-owned specialty pharmacy requirements can delay cancer medications and create financial hardship. The committee reported HB 938 favorably with amendments. The committee also heard HB 1154, which prohibits prior authorization for certain generic medications prescribed by qualified physicians, with a $250 cap discussed as a safeguard against higher-cost generics. The bill was supported by representatives from Ochsner Health and the Louisiana State Medical Society and was reported favorably. HB 909, which requires commercial coverage for behavioral health crisis services, was amended to clarify the insurers covered and then reported favorably with support from the Office of Behavioral Health and several outside groups. Testimony on HB 909 focused on reducing emergency room and law enforcement burdens and expanding crisis response capacity across the state. HB 1187, dealing with excess emergency assessment funds from Louisiana Citizens Property Insurance Corporation, was explained by the Insurance Commissioner as a way to transfer remaining Katrina-era assessment funds to the Fortified Roof Program. The committee reported the bill favorably. Finally, SB 511 and SB 512 were deferred and converted into a study resolution approach because there was not yet consensus on the underlying issue. The meeting then adjourned.

Transcript Highlights:

• Project funding, and also appropriates interest funds up to $14 million to address gaps in the Pharmaceutical
• Project funding, and also appropriates interest funds up to $14 million to address gaps in the Pharmaceutical
• partnerships, and OSU's growing research enterprise to accelerate the discovery and deployment of novel pharmaceutical

Bills: HB1937, HB2153, HB3674, HB2978, HB3885, HB3671, HB3261, HB3021, HB3029, HB4274, HB3701, HB3076, HB2299, HB3852, HB3244, HB3345, HB3114, HB3764, HB4144, HB3304, HB2939, HB4227, HB3262, HB2941, HB3498, HB4343, HB4425, HB3386, HB3087, HB3062, HB3431, HB4141, HB3581, HB4237, HB2960, HB3645, HB3648, HB3974, HB3045, SCR18, HCR1024, SJR39, SJR49, HB4486, SB1130, SB1131, SB1132, SB1133, SB1134, SB1142, HB1823, HB4476, HB3378, HB3880, HB3031, HB3369, HB3429, HB3657, HB4215, HB3624, HB1170

Keywords: HB1937, Oklahoma schools, student communications, electronic communication, digital communication, parent notification, legal guardian, school personnel, teachers, coaches, administrators, charter schools, public schools, administrative leave, corroborated report, investigation, employee file, discipline, termination, school board

Summary: The Senate convened with a quorum, offered the daily prayer, and recognized a series of guests and special introductions, including Langston University Day, Moore Public Schools cheer and pom squads, a student shadow, former Senator Connie Johnson, Brazilian missionaries, and a long-serving mental health employee. The chamber also heard introductions from the day’s pages. The Senate adopted Senate Concurrent Resolution 18, recognizing April 21, 2026, as National Lineman Appreciation Day, and House Concurrent Resolution 1024, designating Route 66 Day at the Capitol and honoring the highway’s centennial. Senators then advanced Senate Joint Resolution 49, which revokes a Wildlife Department rule requiring oil and gas companies to post a surety bond, after discussion clarified the measure was intended to eliminate duplicative regulation; the resolution advanced on a 42-3 vote. The Senate also passed House Bill 4486, authorizing the State Capitol Preservation Commission to arrange a privately funded Gold Star Family Monument near the Capitol Square Arch, and approved several appropriations measures tied to ARPA interest or excess funds. These included Senate Bill 1130 for the University of Oklahoma Hospital Trust Authority’s Child Behavioral Health Project, Senate Bill 1131 for the Office of Juvenile Affairs’ Youth Services Program, Senate Bill 1132 for the Rural Hospital Rebuild Program, Senate Bill 1133 for Griffin Memorial Hospital replacement capacity, Senate Bill 1134 for the Human Performance Project and Pharmaceutical Expansion Project, and Senate Bill 1142 for grants to the Boys & Girls Club and YWCA. Most of these bills were adopted with emergency clauses after roll-call votes, with some members changing votes before final emergency passage. The Senate then announced committee meetings and adjourned until the next scheduled session.

Transcript Highlights:

• I had the privilege of having a significant role in Florida-based organizations, per Coast Pharmaceuticals
• science industry has grown faster than the nation, with double-digit job growth in the drug and pharmaceutical
• nbsp;  484 GROWN FASTER THAN THE NATION WITH DOUBLE DIGIT  JOB GROWTH IN THE DRUG AND PHARMACEUTICAL

Summary: The committee first took up CS/House Bill 981, which would restore the Ocklawaha River and related natural resources. Supporters, including environmental groups, Save the Manatee Club, business owners, and Reunite the Rivers advocates, argued the bill would improve manatee habitat, fish passage, flood protection, tourism, and long-term economic returns while reducing dam maintenance costs. Opponents and skeptics focused on concerns about water quality, nutrient loading in the St. Johns River, loss of the Rodman Reservoir’s habitat and water-supply value, and potential ecological and economic harms. Members in debate largely supported the restoration effort, and the bill was reported favorably on a unanimous vote. The committee then heard HB 697, the PRICE Act, which would use international reference pricing to set a drug cost benchmark, address pharmacy benefit manager practices, and require health plans to keep drug prices stable for the year. The sponsor said the bill would lower costs and improve access, especially for uninsured Floridians. Supporters, including independent pharmacists, argued PBMs are squeezing pharmacies and that the bill could help lower prices. Opponents from BioFlorida and PhRMA warned the proposal could disrupt the national drug supply chain, fail to pass savings to patients, and lead to shortages, reduced access, and less innovation. After debate, the bill passed favorably, with Rep. Chambliss voting no. The committee also considered CS/HB 1081, which was amended to include private colleges and universities with NCA designation in the program. After brief discussion and support from United Way Miami, the committee reported the bill favorably. Finally, CS/HB 177 was introduced as a framework for Florida’s regional councils to cross-assign bills among regions; it received supportive testimony and was also reported favorably. The meeting then adjourned.

Transcript Highlights:

• Let's see, Pharmaceutical Research and Manufacturers of America. William Goo?
• <00:37:32.240><c> research</c><00:37:32.839><c> and</c> pharmaceutical research and pharmaceutical research
• It’s a recent change by the pharmaceutical manufacturers that has limited their ability, so hospitals
• It’s a recent change by the pharmaceutical manufacturers that has limited their ability, so hospitals
• It’s a recent change by the pharmaceutical manufacturers that has limited their ability, so hospitals

Keywords: 910, house, all

Summary: The joint hearing covered HB 553 on biomarker testing coverage, HB 556 on colorectal cancer screening access, and later HB 712 on 340B drug pricing. For HB 553, the American Cancer Society Cancer Action Network, patient advocates Natalie Heyman and Susan Hirano, a surgical oncologist, and the American Lung Association strongly supported the bill, arguing that biomarker testing should be covered when ordered by a doctor and guided by current evidence. DHS and several insurers offered comments and requested amendments, with DHS saying it appreciated the intent but wanted changes. The committees then voted to pass HB 553 with amendments, including a House draft and a defective date of July 1, 3000; both the House Health and Human Services and Homelessness committees adopted the recommendation unanimously. For HB 556, testimony focused on closing gaps in colorectal cancer screening, especially for uninsured and underinsured patients who can get stool-based screening but then cannot access follow-up colonoscopies. Community Clinic of Maui, ACS CAN, and the American Cancer Society supported the bill, with ACS CAN urging a program similar to the breast and cervical cancer control program and offering amendments. DHS requested that the program and appropriation not conflict with executive budget priorities, and the committees noted technical amendments, a defective date, a blank appropriation amount, and corrections changing Medicare references to Medicaid. HB 556 was also passed with amendments by both committees. The hearing then moved to HB 712 on 340B drug pricing and contract pharmacies. The Department of Health and the Attorney General’s office expressed concern that the bill would require the state to regulate private commercial activity and said the department lacked the expertise and resources to implement it as written, suggesting it might belong in a different statutory section. In contrast, PhRMA opposed the bill, while Hawaii Pacific Health and Hawaii Island Community Health Center supported it, saying 340B savings are important for hospital services and patient access to low-cost medications, especially where manufacturers have restricted shipments to contract pharmacies. No vote on HB 712 was taken in the portion provided.

Transcript Highlights:

• Pharmaceutical companies and community health centers are at the negotiating table working with legislators
• In closing, I urge you not to view a vote against this bill as a vote for pharmaceutical companies.
• I am the Washington State representative for PILMA, the Pharmaceutical Industry Labor Management Association
• I am the Washington State Representative for PILMA, the Pharmaceutical Industry Labor Management Association

Bills: SB5877, SB5904, SB5988

Keywords: anesthesiology, medical personnel, surcharges, licensing, healthcare regulations, nursing titles, licensure, healthcare professionals, patient safety, professional standards, opioid treatment, accreditation, health department, fee authority, substance abuse, 904, all

Transcript Highlights:

• Your pharmaceutical used to only be 10 to 12 percent of the health care dollar. Today...
• Your pharmaceutical used to only be 10 to 12% of the health care dollar.
• Phil Christophernelly here on behalf of the Pharmaceutical Care Management Association.
• I represent the Pharmaceutical Care Management Association.
• Large pharmaceutical manufacturers. You know their names.

Bills: HB62, HB124, HB182, HB193, HB198, HB203, HB223, HB237, HB469, HB486, HB574, HB779, HB796, HB919, SCR2, SB4, SB36, SB38, SB109, SB152, SB168, SB195, SB216, SB221, SB236, SB404

Keywords: Louisiana Women's Policy, gender equality, policy research, commission membership, women's representation, Domestic Violence, judicial experience, legislation, criminal law, family law, HB182, sexual assault, rape kit, forensic examination, forensic medical exam, sexual assault survivor, sexual assault nurse examiner, SANE, emergency department, hospital staffing

Transcript Highlights:

• the discussions that have been having around affordability, especially in the space of pharmacy pharmaceuticals
• the discussions that have been having around affordability, especially in the space of pharmacy pharmaceuticals
• of them for questions. been having around affordability, especially in the space of pharmacy pharmaceuticals

Bills: SCR96, SCR109, SCR164, SCR172, SCR166

Keywords: electric reliability, renewable energy, interconnection, Hawaii Electric Reliability Administrator, Public Utilities Commission, capacity shortfalls, energy policies, mail-order pharmacy, insurance, healthcare access, chronic disease management, cost savings, rural access, emergency healthcare, patient adherence, critical infrastructure, foreign influence, local control, energy dependence, economic resilience

Summary: The Committee on Consumer Protection and Commerce heard several Senate concurrent resolutions related to utilities, pharmacy access, critical infrastructure, and energy policy. STR 96 SD1 asked the Public Utilities Commission (PUC) to report on the progress of the Hawaii Electric Reliability Administrator; the PUC offered written comments and the measure later advanced as is. STR 109 SD1 urged the insurance commissioner to study expanding mail-order pharmacy use. Testimony was split: DCCA’s insurance division, HMSA, and the Hawaii Association of Health Plans supported the study, while Shipa and the Hawaii Pharmacist Association opposed it, arguing mail-order pharmacy is already available and that in-person pharmacist counseling should be preserved. The measure was ultimately deferred. The committee also heard STR 164 SD1 on protecting Hawaii’s critical infrastructure from foreign influence. Greenpeace Hawaii and 350 Hawaii strongly supported the resolution, framing it as a consumer protection and resilience measure tied to reducing dependence on imports and strengthening local food and energy systems. No opposition was presented, and the resolution was moved out as is. STR 172 SD1 HD1 directed the PUC to conduct a comprehensive analysis of ways to maximize cost reduction and minimize financial risk while meeting state goals. DCCA, the Hawaii State Energy Office, and the PUC offered comments, and Earthjustice supported the measure; it was also advanced as is. For STR 166 SD1, which concerns how the PUC should evaluate generational energy commitments, DCCA, the Hawaii State Energy Office, and the PUC provided comments, while 350 Hawaii, Greenpeace Hawaii, and others opposed any move toward LNG, arguing it would harm ratepayers and conflict with Hawaii’s renewable goals. After discussion, the committee amended the resolution to add language directing the PUC to evaluate any LNG or other imported-fuel proposal for its potential effects on or delays to the state’s renewable portfolio standards, including the 2045 deadline. The amended resolution then passed, and the committee adjourned.

Transcript Highlights:

• , by the way, is reaping some of the highest profit margins of any drug in the history of the pharmaceutical
• , by the way, is reaping some of the highest profit margins of any drug in the history of the pharmaceutical
• 00:10:35.200><c> history</c><00:10:35.360><c> of</c><00:10:35.519><c> the</c><00:10:35.680><c> pharmaceutical
• </c> the history of the pharmaceutical the history of the pharmaceutical industry<00:10:37.322><c> [clears

Keywords: 00:00 Call to Order 0:22 Roll Call 1:05 SB 65 Discussion 9:30 SB 65 Vote 11:55 SB 177 Discussion 26:34 SB 177 Vote 30:05 SB 245 Discussion 33:07 SB 245 Vote 33:48 Adjournment, 958, all

Transcript Highlights:

• outstanding provider fees and pursuing alternative options that position the agency to negotiate better pharmaceutical
• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• Michael Cantenz representing the Pharmaceutical Care Management Association. Thank you, Chair.
• Michael Cantenz, representing the Pharmaceutical Care Management Association (PCMA).

Bills: S0688, S1414, S0186, S0902, S0196, S1574, S0878, S1092, S1032, S1684, S1686, S1760

Keywords: cytomegalovirus, education, maternal health, newborn care, infectious diseases, student health, epilepsy, seizure disorders, school safety, training requirements, medical marijuana, low-THC cannabis, neurofibromatosis, healthcare, state regulations, child care facilities, public safety, grant program, uterine fibroids, health database

Summary: The committee took up several health-related bills and confirmations. It first heard SB 1414 on congenital cytomegalovirus education, which would require the Department of Health to develop and distribute educational materials to expectant and new parents through maternity, prenatal, newborn, and OB-GYN settings; an amendment removed a section on required instruction for medical professionals, and the bill was reported favorably as a committee substitute. The committee then approved a block of appointees on tabs 2 through 7 and separately confirmed Chavon Harris as Secretary of the Agency for Health Care Administration after her testimony on Medicaid accountability, transparency, managed care oversight, rural health, behavioral health, and the state’s technology modernization efforts. Senators asked Harris about Hope Florida, Medicaid redeterminations, the CORE project, an anti-marijuana ad campaign at DCF, and compliance with a federal Medicaid-related court order; she said she would follow up on some issues. The confirmation was recommended favorably, with Senator Berman voting no. The committee next passed SB 186 on student health and safety, which expands epilepsy and seizure-disorder training requirements to more school personnel, including bus drivers and charter school staff, and requires seizure-first-aid posters and updated Department of Health education efforts. It also approved SB 902 on Department of Health issues after amendments narrowed the bill’s scope and added provisions on medical marijuana regulation, early childhood intervention, practitioner accountability, and autism workforce development; one speaker raised concerns about marijuana dispensary location restrictions and low-THC ratios. SB 196 creating a uterine fibroid research database was also reported favorably after an amendment protecting patient privacy; the bill drew emotional testimony from a patient describing severe symptoms and the need for more research. SB 688 on naturopathic medicine was approved after committee discussion about scope of practice, referral obligations, and whether naturopathic care should be adjunctive to conventional medicine; supporters described complementary care and access issues, while opponents worried about delayed treatment for serious disease. Later, the committee passed SB 1574, “Maddie’s Law,” to add biliary atresia screening to newborn screening using the same blood specimen already collected at birth and to launch an education campaign; parents of a child affected by the disease testified that earlier screening could have prevented severe harm. SB 878 on clinical laboratory personnel was reported favorably to address staffing shortages by allowing Florida to rely more directly on federal CLIA standards for qualified lab workers. SB 1092 on podiatric medicine was approved after an amendment narrowed it to cellular/tissue-based products and podiatrists’ use of certain therapies; the bill also addresses continuing education, informed consent, and advertising disclosures. SB 1032 on medical marijuana was amended and passed, aligning physician certification and card renewal timelines, setting 70-day and 35-day supply limits, and reducing the fee for honorably discharged veterans while preserving funding for FAMU; Senator Harrell opposed it, saying the longer timeframes were too much of an expansion. The committee also heard SB 1760 on Medicaid coverage transparency from Senator Brodeur, who said the bill focuses on accountability and fiscal responsibility, but the transcript cuts off before further discussion or action on that measure.

Transcript Highlights:

• We've also pursued alternative options that position the agency to negotiate better pharmaceutical rebates
• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• Michael Cantenz, representing the Pharmaceutical Care Management Association. Thank you, Chair.
• Michael Cantenz, representing the Pharmaceutical Care Management Association.

Keywords: 999, senate, all

Transcript Highlights:

• :14.760><c> care</c><00:07:14.960><c> providers</c><00:07:15.480><c> and</c><00:07:15.640><c> pharmaceutical
• </c> health care providers and pharmaceutical health care providers and pharmaceutical companies<00:07
• ><c> to</c><00:07:53.640><c> attack</c> agriculture, not to attack agriculture, not to attack pharmaceutical
• > companies,</c><00:07:55.520><c> not</c><00:07:55.840><c> to</c><00:07:55.960><c> attack</c> pharmaceutical
• companies, not to attack pharmaceutical companies, not to attack processed<00:07:56.960><c> food</c>

Keywords: Roll Call - 00:10 Discussion on SCR 61 – 01:46 Vote on SCR 61 – 11:33 Discussion on SR 18 – 12:30 Vote on SR 18 - 30:01 Discussion on Ky Residential Autism Services – 32:34 Questions & Comments – 56:56, 958, all

Summary: The committee met with a quorum and first considered Senate Concurrent Resolution 61, sponsored by Senator Shelley Funke Frommeyer and Representative Matt Lockett. The resolution, as amended by committee substitute, would create a legislative task force tied to the MAHA (Make America Healthy Again) framework to study Kentucky health policy, including Medicaid drug approvals, preventive and alternative therapies, holistic health education, oversight and transparency in health care, and research into integrative approaches. Supporters said the goal was to address chronic disease and reduce over-medication, while emphasizing the effort was not intended as an attack on agriculture or the pharmaceutical industry. The resolution received favorable expression and passed the committee 9-0. The committee then heard Senate Resolution 18 from Senator Neal, urging Kentucky to maximize participation in the federal SNAP Employment and Training (SNAP E&T) program. Testimony from Jessica Klein of the Kentucky Center for Economic Policy and Secretary Eric Friedlander explained that SNAP E&T provides job training, education, and support services for SNAP participants, and that the program is federally matched and does not require additional General Assembly funding in the normal course. Members discussed how the program works, whether it could create new state costs, and how it fits with efforts to connect food assistance, workforce development, and local agriculture. Questions also focused on whether SNAP spending can be steered toward healthier foods and farmers markets, including Kentucky’s Double Dollars program, which was described as helping participants buy produce, meat, and dairy at participating markets and some retailers. Several members expressed support for the workforce goals but asked for more information on fiscal impacts and purchasing data. Secretary Friedlander said the SNAP E&T funds are separate from nutrition benefits, and that the state match generally comes from employer, university, or workforce partner contributions rather than new state appropriations. Senator Herron explained her vote in favor by saying the program could help people gain education and employment and reduce reliance on SNAP over time. Senate Resolution 18 was then adopted by the committee.

Transcript Highlights:

• They already have use, like the pharmaceutical side.
• They're going to use the minerals for the pharmaceutical development. So they have that in place.
• The minerals for the pharmaceutical development. So they have that in place already.

Summary: The committee first heard House Bill 2510, sponsored by Rep. Steinmeier, which would create a coordinated state framework for critical minerals involving the Departments of Natural Resources, Economic Development, and Higher Education and Workforce Development. The sponsor said Missouri is well positioned because it contains 36 of 60 minerals deemed critical to national security and manufacturing, and argued the bill would help Missouri pursue federal funding, build a workforce pipeline, and support advanced manufacturing with a five-year sunset. Committee members questioned the need for a new state structure and fund, the cost to Missouri, the role of universities, and whether the task force was too narrowly written around the University of Missouri system and mistakenly included DESE instead of higher education. A Missouri Chamber witness supported the bill for its economic and national security benefits, while an environmental witness urged adding an environmental professional to the task force and a mining permitting framework, citing health and water concerns and suggesting a separate mining-regulation bill as an amendment. The committee then took up House Bill 2585, sponsored by Rep. Castile, which updates Missouri workforce development statutes to align with federal law and implement the new Workforce Pell Grant program. The sponsor said the bill would allow short-term, high-value training programs in fields like welding, public safety academies, health technology, and trucking to qualify for Pell support, while preserving oversight and tying eligibility to outcomes such as completion, job placement, and earnings. Members asked about the number and makeup of the workforce board, whether the bill’s staffing references still pointed to the wrong department, how the 150% poverty-level threshold and reporting metrics would work, and whether the board could move quickly enough to meet federal timelines. A Missouri Community College Association witness said all 12 community colleges have programs likely to qualify and explained the federal eligibility standards, including a 70% completion rate, 70% job placement rate, and three-year rolling data review; a FGA Action witness and the Missouri Chamber also supported the bill as a way to expand access to skills training and draw down federal funds. After the bill hearings, the committee received an informational presentation from the Midwestern Higher Education Compact. The presenter described the compact’s regional cost-saving work, including reciprocity for distance education, technology contracts, grants, and efforts on dual credit and FAFSA support. She also shared Missouri-specific data on educational attainment, enrollment trends, student migration, and net price, noting that Missouri lags slightly behind the U.S. in attainment, has projected declines in high school graduates, retains most in-state students, and has higher net prices for low-income students than the Midwest average. The committee then adjourned.

Transcript Highlights:

• This is for pharmaceutical breakthroughs, battery breakthroughs, chemistry breakthroughs, the likes of
• intellectual property generated from the quantum computers, whether it's sort of like a new formula for pharmaceuticals
• This is not a long-term application like maybe pharmaceutical breakthroughs are.

Bills: SB151, HB8, SB177

Keywords: corporate income tax, franchise tax, gross receipts tax, tax credit, tax deduction, controlled foreign corporation, CFC, bonus depreciation, interest expense, apportionment, unitary group, high-wage jobs tax credit, local journalism, news media, newspaper printer, physician incentive, health care workforce, affordable housing, multifamily housing, construction materials

Transcript Highlights:

• There's a lot of potential for pharmaceuticals to be discovered and developed in the oceans.
• There's a lot of potential for pharmaceuticals. RX symbol in the ocean.
• There's a lot of potential for pharmaceuticals to be discovered and developed in the oceans.

Summary: The Committee on Education Postsecondary heard a presentation on Florida’s maritime and ocean economy from Florida Atlantic University, the College of the Florida Keys, and Star Center. Speakers emphasized the importance of maritime industries such as aquaculture, marine engineering, shipbuilding, transportation, coastal resilience, and offshore renewable energy, and described workforce programs, certifications, and partnerships designed to train students and workers for these fields. They also highlighted federal and state initiatives supporting ocean economy research and commercialization, including tech hubs and innovation programs. The committee then considered SB 312 relating to the Florida Institute of Human and Machine Cognition. Senator Gates explained that the bill would allow IHMC to create a subsidiary to commercialize research, similar to Moffitt Cancer Center. Senator Fine offered and the committee adopted a friendly amendment addressing board membership concerns tied to a University of West Florida trustee. However, after questions arose about whether the bill and analysis aligned on whether subsidiaries would be for-profit or not-for-profit, the bill was tabled. Finally, the committee took up SB 270 on the Bright Futures Scholarship Program. The bill would extend eligibility for students in certain military/public-service family situations, giving families more time to establish Florida residency after returning to the state. Senator Fine’s amendment was adopted to add AP Capstone Diploma students to the automatic Bright Futures eligibility provisions, alongside IB and Cambridge AICE students. The committee then reported the bill favorably as amended by a vote of 7-0, and adjourned.

Transcript Highlights:

• Budget to recommend policies to improve competitiveness, efficiency, and transparency in the pharmaceutical
• And then, uh, another area is streamlining domestic production of pharmaceutical drugs.
• it's looking at, um, removing some of the, the building requirements for the factories that make pharmaceutical
• president directed the Secretary of Health and Human Services to, um, Basically, come to all of the pharmaceutical

Transcript Highlights:

• Oklahoma State University Medical Authority to address address gaps in the human performance and pharmaceutical
• Yeah, this is for the two projects. $14 million will be going to the pharmaceutical program.

Keywords: 914, all

Transcript Highlights:

• But the problem is these are pharmaceutical products that have... injury and death, including over 3
• Medical care and pharmaceuticals. It goes back to your insulin, getting the insulin processed down.
• My awareness on pharmacy deals with people who I talk to about what's going on in the pharmaceutical
• While pharmaceutical companies enjoy liability-free profits, and to state the obvious, I'm not going
• Um, you know, we are not also holding pharmaceuticals accountable if they have a vaccine that causes

Bills: SB95, SB268, SB493, SB619, SB660, SB922, SB984, SB1098, SB1188, SB1307, SB1332, SB1822

Keywords: immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit

Transcript Highlights:

• the 16,000 children that are diagnosed every single year, the margins aren't good enough for pharmaceutical
• And this is because development for childhood cancer drugs is not seen as profitable by pharmaceutical
• Just to explain: the first level is no privileges of any pharmaceutical agents at all; the second level
• is use of diagnostic pharmaceutical agents only; the third level is diagnostic and therapeutic topical
• agents at all the second level is use of diagnostic uh pharmaceutical agents only the third level is

Keywords: 995, all

Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on children’s health, tobacco control, newborn screening, pediatric cancer, palliative care, and professional licensure. Early testimony highlighted Senate bills to expand newborn screening for pyruvate dehydrogenase complex deficiency, lysosomal storage disorders, and congenital CMV, with families and clinicians describing severe diagnostic delays, missed treatment windows, and the benefits of early detection. Speakers also supported a bill to improve pediatric cancer research through a dedicated trust fund, and a bill to extend pediatric palliative care services to age 22, with parents and providers emphasizing continuity of care for seriously ill young people. Several witnesses gave personal accounts in support of the newborn screening measures. Families described children who endured years of misdiagnosis before receiving diagnoses such as Gaucher disease, Fabry disease, Pompe disease, Niemann-Pick disease, and CMV, often after irreversible damage had already occurred. Medical and advocacy witnesses said Massachusetts already collects some of the relevant screening data and argued that results should be reported to families, while others urged the committee to add conditions to the state panel because effective treatments already exist. The committee also heard support for a bill to establish a fetal alcohol spectrum disorder program and training for providers. On tobacco and youth health, testimony supported bills to ban internet tobacco sales, strengthen youth protections, and reduce lung cancer deaths through point-of-sale information and quit-line access. A student testified about easily purchasing flavored nicotine products online without meaningful age verification, and public health advocates backed measures to keep tobacco out of children’s environments. The committee also heard testimony on a bill to ensure parents have access to their children’s medical records through age 16, with exceptions for sensitive services already protected by law. The committee additionally took testimony on an optometry licensure bill, where ophthalmologists opposed language they said could broaden scope of practice and allow optometrists to use the title “optometric physician,” while optometry educators and students supported the bill as a modernization measure with no scope expansion. No votes were taken during the hearing; the chair repeatedly reminded speakers of time limits and noted that written testimony could be submitted for additional comments.